Quick Takeaways
- Aymeric Sallin has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $546,800.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Aymeric Sallin
- Location
- Grand Cayman, Cayman Islands
- Summary
- The estimated net worth of Aymeric Sallin is at least $546,800 dollars as of 04 Jan 2024. Aymeric Sallin is the Director of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $546.8K.
- Signature
- /s/ Matthew Bartholomae, Attorney-in-Fact for Aymeric Sallin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Aymeric Sallin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Cartesian Therapeutics, Inc. ($546,800).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Aymeric Sallin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Director | $546,800 | 02 Jan 2024 |
Insider Transactions Reported by Aymeric Sallin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.